LicianPro

TLSI stock

TriSalus Life Sciences (TLSI) financials · rev $45.2M

Compare AAPL vs MSFT

TriSalus Life Sciences (TLSI) rev $45.2M.

Annual income statement
LineFY2025FY2024Pro (2 older periods with Lician Pro)
Revenue$45.15M$29.43M
Cost of Revenue$6.96M$4.10M
Gross Profit$38.19M$25.33M
Operating Income−$26.95M−$36.16M
Net Income−$39.23M−$30.05M
EPS (Diluted)−$1.84−$1.31
Unlock 5 years of statements: Lician Pro $149/yr
Annual balance sheet
LineFY2025FY2024Pro (3 older periods with Lician Pro)
Total Assets$35.33M$23.97M
Current Assets$32.24M$20.67M
Cash & Equivalents$20.44M$8.53M
Inventory$3.08M$4.05M
Total Liabilities$69.19M$49.87M
Current Liabilities$11.50M$10.23M
Long-term Debt$33.05M$22.08M
Total Debt$33.05M$22.08M
Shareholders' Equity−$33.86M−$25.89M
Retained Earnings−$330.58M−$279.55M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

Annual cash flow
LineFY2025FY2024Pro (2 older periods with Lician Pro)
Operating Cash Flow−$18.01M−$40.84M
CapEx$918.00K$345.00K
Investing Cash Flow−$838.00K−$345.00K
Financing Cash Flow$30.76M$37.94M
Net Change in Cash$11.91M−$3.25M
Free Cash Flow−$18.93M−$41.19M

Source: Company filings with the SEC (EDGAR) · Latest period FY2025

These statements as JSON? API free 100/day

FAQ

What is TLSI P/E and revenue?

TriSalus Life Sciences (TLSI) rev $45.2M.

What is TLSI revenue?

TriSalus Life Sciences last cached revenue is $45.2M (FY2025).

Is TLSI profitable?

TriSalus Life Sciences last cached net income is -$39.2M (FY2025).

What are TLSI total assets?

TriSalus Life Sciences last cached total assets are $35.3M (FY2025).

What is TLSI free cash flow?

TriSalus Life Sciences last cached free cash flow is -$18.9M (FY2025).

Not investment advice. Figures as reported in company filings, not a live feed.